Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

152
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The "Hit-and-Run" legacy: epigenetic locking and the survival switch in H. pylori-associated gastric cancer.

Cell death discovery·2026
Same author

Beyond non-anatomical resections: Is minimally invasive parenchyma-sparing anatomical hepatectomy the next chapter?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Comparison of robotic and open liver resections for primary liver tumors: a multicenter retrospective analysis of perioperative outcomes, morbidity and mortality.

Surgical endoscopy·2026
Same author

Does complexity compromise outcomes in robotic hepatectomy?

Surgical endoscopy·2025
Same author

Updating Clinical Management of Cystic and Alveolar Echinococcosis: Insights and Challenges.

Visceral medicine·2025
Same author

Safety of robotic hepatic parenchymal transection using scissor hepatectomy and alternative techniques: a cohort study.

Surgical endoscopy·2025
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
Same journal

Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction.

Seminars in cancer biology·2026
See all related articles

Related Experiment Video

Updated: Nov 3, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

11.4K

Curing pancreatic cancer.

Benno Traub1, Karl-Heinz Link2, Marko Kornmann1

  • 1Clinic for General and Visceral Surgery, University of Ulm, Albert-Einstein Allee 23, Ulm, Germany.

Seminars in Cancer Biology
|June 1, 2021
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer presents significant challenges due to its aggressive nature and resistance to therapy. Advances in treatment and research collaboration offer hope for improved outcomes and cures.

Keywords:
(Neo-)adjuvant treatmentOncogenesisPancreatic cancerSurgeryTranslational research

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.1K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.8K

Related Experiment Videos

Last Updated: Nov 3, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

11.4K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.1K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.8K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Translational Research

Background:

  • Pancreatic cancer is characterized by aggressive biology, late diagnosis, and therapeutic resistance, leading to poor prognoses.
  • It is projected to become the second leading cause of cancer-related deaths, with surgery as the only curative option.
  • Current treatment options are limited, affecting only a minority of patients with grim long-term outcomes.

Purpose of the Study:

  • To review the current clinical and biological features of pancreatic cancer.
  • To summarize existing surgical and non-surgical treatment strategies.
  • To highlight the importance of collaboration between clinicians and basic researchers for advancing pancreatic cancer care.

Main Methods:

  • Literature review of clinical and biological aspects of pancreatic cancer.
  • Analysis of current surgical and neoadjuvant/adjuvant treatment modalities.
  • Examination of advancements in early detection, tumor modeling, and personalized medicine.

Main Results:

  • Despite challenges, new developments in neoadjuvant and adjuvant therapies are increasing surgical eligibility.
  • Improved perioperative care and complication management enhance patient outcomes.
  • Basic research is crucial for developing novel early detection and personalized treatment approaches.

Conclusions:

  • Enhanced collaboration between clinicians and basic researchers is vital for overcoming pancreatic cancer's challenges.
  • Continued advancements in early detection, treatment, and personalized medicine are essential for improving cure rates.
  • The review synthesizes current knowledge to guide future research and clinical practice towards more effective pancreatic cancer therapies.